Cytokinetics Inc
(NAS:CYTK)
$
52.22
-0.56 (-1.06%)
Market Cap: 6.12 Bil
Enterprise Value: 6.32 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 41/100 - Q1 2024 Cytokinetics Inc Earnings Call TranscriptMay 08, 2024$65.27 (-0.02%)Earnings
- Q4 2023 Cytokinetics Inc Earnings Call TranscriptFeb 27, 2024$80.99 (+2.52%)Earnings
- Cytokinetics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Cytokinetics Inc to Discuss the Topline Results from SEQUOIA-HCM TranscriptDec 27, 2023
- Cytokinetics Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Cytokinetics Inc Earnings Call TranscriptNov 02, 2023$34.64 (-1.31%)Earnings
- Cytokinetics Inc To Host Virtual Investor & Analyst Day TranscriptOct 19, 2023
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Cytokinetics Inc Earnings Call TranscriptAug 03, 2023$31.7 (+1.99%)Earnings
- Cytokinetics Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Cytokinetics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Cytokinetics Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 10, 2023
- Q1 2023 Cytokinetics Inc Earnings Call TranscriptMay 04, 2023$39.29 (-0.13%)Earnings
- Cytokinetics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Cytokinetics Inc To Discuss COURAGE-ALS Update Call TranscriptMar 31, 2023
- Cytokinetics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Cytokinetics Inc ACC.23 Conference Call TranscriptMar 06, 2023
- Q4 2022 Cytokinetics Inc Earnings Call TranscriptMar 01, 2023$43.11 (-0.58%)Earnings
- Cytokinetics Inc To Discuss Omecamtiv Mecarbil Regulatory Update Call TranscriptMar 01, 2023
- Cytokinetics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Cytokinetics Inc FDA Advisory Committee for Omecamtiv Mecarbill Update Call TranscriptDec 14, 2022
- Q3 2022 Cytokinetics Inc Earnings Call TranscriptNov 03, 2022$39.75 (-5.06%)Earnings
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Cytokinetics Inc Earnings Call TranscriptAug 04, 2022$46.72 (+9.06%)Earnings
- Cytokinetics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2022
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 10, 2022
- Q1 2022 Cytokinetics Inc Earnings Call TranscriptMay 04, 2022$41.03 (+2.58%)Earnings
- Cytokinetics Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Q4 2021 Cytokinetics Inc Earnings Call TranscriptFeb 24, 2022$33.95 (+8.29%)Earnings
- Cytokinetics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Cytokinetics Inc and Royalty Pharma Funding Agreements Call TranscriptJan 07, 2022
- Cytokinetics Inc and Ji Xing Pharmaceuticals Ltd Call to Discuss Announced Expansion of Collaboration TranscriptDec 20, 2021
- Q3 2021 Cytokinetics Inc Earnings Call TranscriptNov 03, 2021$36.67 (+5.74%)Earnings
- Cytokinetics Inc Analyst and Investor Day TranscriptOct 07, 2021
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Cytokinetics Inc Call to Discuss the Full Results from REDWOOD-HCM TranscriptSep 13, 2021
- Q2 2021 Cytokinetics Inc Earnings Call TranscriptAug 05, 2021$30.24 (+2.47%)Earnings
- Cytokinetics Inc to Discuss Positive Topline Results of Redwood-HCM Call TranscriptJul 19, 2021
- Cytokinetics Inc at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 21, 2021
- Cytokinetics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 12, 2021
- Q1 2021 Cytokinetics Inc Earnings Call TranscriptMay 06, 2021$23.37 (-0.89%)Earnings
- Cytokinetics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Q4 2020 Cytokinetics Inc Earnings Call TranscriptFeb 25, 2021$19.85 (-4.34%)Earnings
- Cytokinetics Inc Investor Event TranscriptNov 23, 2020
- Cytokinetics Inc GALACTIC-HF Investor/Media Event TranscriptNov 13, 2020
- Q3 2020 Cytokinetics Inc Earnings Call TranscriptNov 04, 2020$18 (+7.66%)Earnings
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Cytokinetics Inc Earnings Call TranscriptAug 06, 2020$21.64 (-2.21%)Earnings
- Cytokinetics Inc Virtual Analyst & Investor Day TranscriptJul 15, 2020
- Cytokinetics Inc Licensing Collaboration And Royalty Monetization Deals With RTW Investments Focused To CK-274 Corporate Call TranscriptJul 14, 2020
- Cytokinetics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 13, 2020
- Q1 2020 Cytokinetics Inc Earnings Call TranscriptMay 06, 2020$16.63 (+1.28%)Earnings
- Q4 2019 Cytokinetics Inc Earnings Call TranscriptMar 03, 2020$14.57 (+2.32%)Earnings
- Q3 2019 Cytokinetics Inc Earnings Call TranscriptOct 31, 2019$11.65 (-1.60%)Earnings
- Cytokinetics Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Cytokinetics Inc Earnings Call TranscriptAug 08, 2019$13.63 (+2.02%)Earnings
- Cytokinetics Inc at JMP Securities Life Science Conference TranscriptJun 19, 2019
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 15, 2019
- Q1 2019 Cytokinetics Inc Earnings Call TranscriptMay 09, 2019$9.01 (+0.78%)Earnings
- Cytokinetics Inc Discusses Results from FORTITUDE-ALS TranscriptMay 06, 2019
- Cytokinetics Inc at Needham Healthcare Conference TranscriptApr 10, 2019
- Cytokinetics Inc at H C Wainwright Global Life Sciences Conference TranscriptApr 08, 2019
- Q4 2018 Cytokinetics Inc Earnings Call TranscriptFeb 21, 2019$7.21 (-1.77%)Earnings
Cytokinetics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 09, 2021 / 07:00PM GMT
Release Date Price:
$21.53
(-0.87%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
All right. Well, good afternoon, everyone, and welcome to the 3:00 p.m. Eastern Time session here on Day 2 of the 42nd Annual Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh, and I cover U.S. and European Biopharma companies here at the firm. It's my great pleasure to be hosting Cytokinetics today in a fireside chat. And with that, let me welcome the company's CEO, Robert Blum; and the company's Head of R&D, Fady Malik. Gentlemen, great to see you both, and welcome to the conference.
Robert I. Blum
Cytokinetics, Incorporated - CEO, President & Director
Thank you, Graig. Thank you for having us here.
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
I believe that, Robert, you wanted to start off with perhaps some introductory comments, and I think you have a slide deck that you want to share.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)